G
NVO

GlobalBridge’s Novo Nordisk NVO Stock Holding History

GlobalBridge’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$744K Buy
32,598
+1,468
+5% +$31.3K 0.35% 100
2013
Q4 		$575K Buy
31,130
+1,240
+4% +$21.6K 0.29% 140
2013
Q3 		$506K Buy
29,890
+1,250
+4% +$21K 0.27% 148
2013
Q2 		$444K Buy
+28,640
New +$477K 0.24% 158

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

GlobalBridge's NVO Position: Q1 2014 in Review

GlobalBridge increased its Novo Nordisk (NVO) stake by 4.7% in Q1 2014, buying an estimated $31.3K and bringing the position to 32,598 shares worth $744K. The position accounts for 0.35% of the portfolio, ranked #100.

GlobalBridge first reported a position in NVO in Q2 2013 and has held it in 4 quarters since. 461 funds tracked by Wall St. Rank hold NVO as of Q1 2014.

  • GlobalBridge held 32,598 shares of Novo Nordisk worth $744K as of Q1 2014.
  • GlobalBridge bought 1,468 Novo Nordisk shares in Q1 2014, an estimated $31.3K.
  • Novo Nordisk made up 0.35% of GlobalBridge's portfolio in Q1 2014, its #100 holding.
  • GlobalBridge first reported a position in Novo Nordisk in Q2 2013 and has held it in 4 quarters since.
  • 461 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2014.

Based on GlobalBridge's 13F filing for Q1 2014, filed 8 Apr 2014.